Business
Bacil Pharma Ltd Press Release Mar 24 2025
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakash Bhoorchand Shah
About this update from Bacil Pharma Ltd
[{"type":"text","content":" The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakash Bhoorchand ShahView Attachment","length":328,"tagName":"div"}]